Literature DB >> 18396199

Surgical treatment of metastatic disease to the lung.

Roderick M Quiros1, Walter J Scott.   

Abstract

The presence of distant metastases usually implies disease not amenable to cure through surgical resection. In such cases, chemotherapy is the mainstay of treatment, with surgery or radiation reserved for palliative measures. However, metastases limited to the lung may be resected with resultant prolonged patient survival compared to unresectable, widely disseminated metastases. Isolated pulmonary metastases should therefore not be considered untreatable. In this review, we discuss the pathophysiology of pulmonary metastases. We outline prognostic factors associated with metastases, and propose criteria to help select patients for metastasectomy. Surgical approaches, including various open techniques and video-assisted thoracoscopy, are covered. Surgical issues, including the need for unilateral versus bilateral exploration, the extent of resection to achieve cure, the need for lymph node dissection, and the benefit of repeat operations, are discussed. Finally, we review some of the more common tumors that metastasize to the lungs, and the role of metastasectomy in their treatment. Resection of pulmonary metastases confers a survival benefit to a select group of patients so long as the primary tumor is controlled, metastases are limited to the lungs, the patient can tolerate the operation from a cardiopulmonary standpoint, and the metastases are completely resected.

Entities:  

Mesh:

Year:  2008        PMID: 18396199     DOI: 10.1053/j.seminoncol.2007.12.010

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  8 in total

1.  Editorial on "Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?"

Authors:  Stefano M M Basso; Sandro C Sulfaro; Paolo Ubiali
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

2.  A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.

Authors:  Haruchika Yamamoto; Hiromasa Yamamoto; Junichi Soh; Etsuji Suzuki; Kei Namba; Ken Suzawa; Kentaroh Miyoshi; Shinji Otani; Mikio Okazaki; Seiichiro Sugimoto; Masaomi Yamane; Takashi Yorifuji; Katsuhito Takahashi; Shinichi Toyooka
Journal:  Ann Surg Oncol       Date:  2020-11-24       Impact factor: 5.344

3.  Multimodality therapy for metastatic sarcomas confined to the lung.

Authors:  Russell P Gollard; J Francis Turner
Journal:  Oncol Lett       Date:  2012-07-24       Impact factor: 2.967

Review 4.  The management of the advanced colorectal cancer: management of the pulmonary metastases.

Authors:  Charalambos Zisis; Kosmas Tsakiridis; Ioanna Kougioumtzi; Paul Zarogoulidis; Kaid Darwiche; Nikolaos Machairiotis; Bojan Zaric; Nikolaos Katsikogiannis; Georgios Kesisis; Aikaterini Stylianaki; Zhigang Li; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

Review 5.  Pancreatic Metastases from Tumors in the Urogenital Tract.

Authors:  Olive Strobel; Markus W Büchler
Journal:  Gastrointest Tumors       Date:  2015-06-06

6.  Surgical treatment of metastatic diseases to the lung.

Authors:  Jarosław Religioni; Tadeusz Orłowski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-07-20

7.  Extended resection in pancreatic metastases: feasibility, frequency, and long-term outcome: a retrospective analysis.

Authors:  Georg Wiltberger; Julian Nikolaus Bucher; Felix Krenzien; Christian Benzing; Georgi Atanasov; Moritz Schmelzle; Hans-Michael Hau; Michael Bartels
Journal:  BMC Surg       Date:  2015-12-11       Impact factor: 2.102

8.  Survival by histology among patients with bone and soft tissue sarcoma who undergo metastasectomy: protocol for a systematic review and meta-analysis.

Authors:  Ying Wang; Megan Delisle; Denise Smith; Amirrtha Srikanthan
Journal:  Syst Rev       Date:  2020-08-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.